JP7553619B2 - 低pHウイルス不活化のための新しい連続フロー反応器 - Google Patents
低pHウイルス不活化のための新しい連続フロー反応器 Download PDFInfo
- Publication number
- JP7553619B2 JP7553619B2 JP2023011968A JP2023011968A JP7553619B2 JP 7553619 B2 JP7553619 B2 JP 7553619B2 JP 2023011968 A JP2023011968 A JP 2023011968A JP 2023011968 A JP2023011968 A JP 2023011968A JP 7553619 B2 JP7553619 B2 JP 7553619B2
- Authority
- JP
- Japan
- Prior art keywords
- virus inactivation
- alternating
- reactor
- bends
- tubular
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000002779 inactivation Effects 0.000 title claims description 62
- 241000700605 Viruses Species 0.000 title claims description 40
- 238000000034 method Methods 0.000 claims description 26
- 230000003612 virological effect Effects 0.000 claims description 26
- 230000003068 static effect Effects 0.000 claims description 19
- 239000012530 fluid Substances 0.000 claims description 13
- 102000004169 proteins and genes Human genes 0.000 claims description 11
- 108090000623 proteins and genes Proteins 0.000 claims description 11
- 238000002156 mixing Methods 0.000 claims description 10
- 238000004891 communication Methods 0.000 claims description 4
- 239000006174 pH buffer Substances 0.000 claims description 3
- 230000008569 process Effects 0.000 description 14
- 239000000700 radioactive tracer Substances 0.000 description 13
- 238000009826 distribution Methods 0.000 description 11
- 239000006185 dispersion Substances 0.000 description 10
- 238000009792 diffusion process Methods 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 6
- 238000013461 design Methods 0.000 description 5
- 241000894007 species Species 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 238000004088 simulation Methods 0.000 description 4
- 238000013459 approach Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 239000003929 acidic solution Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000011143 downstream manufacturing Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000010200 validation analysis Methods 0.000 description 2
- 238000012935 Averaging Methods 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 238000001057 Duncan's new multiple range test Methods 0.000 description 1
- 108020004437 Endogenous Retroviruses Proteins 0.000 description 1
- 239000012901 Milli-Q water Substances 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000005571 anion exchange chromatography Methods 0.000 description 1
- 238000011091 antibody purification Methods 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 238000004422 calculation algorithm Methods 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 238000005277 cation exchange chromatography Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000011210 chromatographic step Methods 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000005094 computer simulation Methods 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000012444 downstream purification process Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000005374 membrane filtration Methods 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000003534 oscillatory effect Effects 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 230000002572 peristaltic effect Effects 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000004886 process control Methods 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 241001430294 unidentified retrovirus Species 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/02—Form or structure of the vessel
- C12M23/06—Tubular
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M27/00—Means for mixing, agitating or circulating fluids in the vessel
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M47/00—Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M47/00—Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
- C12M47/12—Purification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Sustainable Development (AREA)
- Clinical Laboratory Science (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Physical Or Chemical Processes And Apparatus (AREA)
- Apparatus For Disinfection Or Sterilisation (AREA)
Description
実施例
実施例1-計算流体力学
結果の例
流れ動力学の結果
滞留時間分布(RTD)の結果
、この式で表されたF曲線(累積分布曲線)が0.005に等しい(F0.005)時間として近似される。実験モデルとCFDモデルとに関する無次元E曲線が、比較のために、図6(a)(b)に示されるように、50及び100ml/分(Reは187.7及び375.5)で夫々プロットされた。経験的データは、各流量に対して3回の実験の結果を平均することによって生成された。
JIBにおける圧力損失の結果
スケーリング結果
実施例からの結論
Claims (19)
- ウイルス不活性化装置であって、
入口と出口との間に蛇行パターンを形成する交互交代する曲がり部の組を備えた管状流路を含む、少なくとも1つの連続ウイルス不活化反応器、
を備え、
前記管状流路は、0.6cm~0.7cmの直径を含み、
前記交互交代する曲がり部の組は、少なくとも2つの積み重ねられた層に垂直に分割されており、
前記少なくとも2つの積み重ねられた層の各々は、0.7cm~1.2cmの厚さを含む、ウイルス不活性化装置。 - 前記少なくとも1つの連続ウイルス不活化反応器は、インライン管状連続ウイルス不活化反応器である、請求項1に記載のウイルス不活性化装置。
- 前記交互交代する曲がり部の組は、270°~280°の角度を有する少なくとも2つの交互交代する曲がり部を含む、請求項1に記載のウイルス不活性化装置。
- 前記交互交代する曲がり部の組は、270°~280°の角度を有する2~325の交互交代する曲がり部を含む、請求項1に記載のウイルス不活性化装置。
- 前記少なくとも2つの積み重ねられた層の各々は、単一面内に12.5の交互交代する曲がり部を含み、前記交互交代する曲がり部の各々は、270°~280°の角度を含む、請求項1に記載のウイルス不活性化装置。
- 前記少なくとも2つの積み重ねられた層の各々は、前記管状流路の1つの180°曲がり部を介して互いに接続されている、請求項1に記載のウイルス不活性化装置。
- 前記少なくとも2つの積み重ねられた層は、前記管状流路の25個の180°曲がり部を介して互いに接続された26層である、請求項6に記載のウイルス不活性化装置。
- 前記少なくとも1つの連続ウイルス不活化反応器は、直列に接続された2~6のウイルス不活化反応器を含む、請求項1に記載のウイルス不活性化装置。
- 前記交互交代する曲がり部の組は、渦を生成して、187.7~375.5のレイノルズ数を備える層流を有する生成物ストリームの混合を誘発するように配置されている、請求項1に記載のウイルス不活性化装置。
- ウイルス不活化装置であって、
第1の静的混合器と流体連絡する入口と、第2の静的混合器と流体連絡する出口とを有する低pH連続ウイルス不活化反応器、
を含み、
ここで、前記低pH連続ウイルス不活化反応器は、交互交代する曲がり部の組で形成された管を含み、
前記管は、0.6cm~0.7cmの直径を含み、
交互交代する前記曲がり部の組は、少なくとも2つの積み重ねられた層に垂直に分割されており、
前記少なくとも2つの積み重ねられた層の各々は、0.7cm~1.2cmの厚さを含む、ウイルス不活性化装置。 - 前記交互交代する曲がり部の組における各曲がり部が、270°~280°までの角度を含む、請求項10に記載のウイルス不活性化装置。
- 前記交互交代する曲がり部の組は、0.85cm~2cmの曲率半径を含む、請求項10に記載のウイルス不活性化装置。
- 前記管は、325の交互交代する曲がり部を含む、請求項10に記載のウイルス不活性化装置。
- 前記管は、25個の管状流路であって、その各々が1つの180°曲がり部を有しているものによって、互いに接続された26層の垂直層に分割されている、請求項10に記載のウイルス不活性化装置。
- 前記管は、少なくとも12.5回の交互交代する曲がり部を単一の面内に含んでいる、請求項10に記載のウイルス不活性化装置。
- 前記低pH連続ウイルス不活化反応器は、直列に接続された2~6のウイルス不活化反応器を含んでいる、請求項10に記載のウイルス不活性化装置。
- 生成物ストリームの連続低pHウイルス不活化のための方法であって、
前記生成物ストリームを、そのpHを所定のウイルス不活化pHにまで下げるために、第1の静的混合器に導入すること、
不活性化されるために前記第1の静的混合器を出る前記生成物ストリームを、単一面内に複数の曲がり部の組を有する管の入口に導入すること、
ここで、前記管は、0.6cm~0.7cmの直径を含み、
交互交代する前記曲がり部の組は、少なくとも2つの積み重ねられた層に垂直に分割されており、
前記少なくとも2つの積み重ねられた層の各々は、0.7cm~1.2cmの厚さを含み、
前記生成物ストリームをウイルス不活化条件下で前記管を通して流すこと、及び
前記生成物ストリームを前記管の出口を通して前記管から出すこと、
を包含し、
ここで、前記生成物ストリームの前記pHを下げるために、低pH緩衝液が前記第1の静的混合器に導入される、方法。 - 単一面内の前記複数の曲がり部は、蛇行パターンを形成している、請求項17に記載の方法。
- 前記生成物ストリームは、プロテインA捕捉器から前記第1の静的混合器に導入される、請求項17に記載の方法。
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862742534P | 2018-10-08 | 2018-10-08 | |
US62/742,534 | 2018-10-08 | ||
PCT/US2019/054959 WO2020076681A1 (en) | 2018-10-08 | 2019-10-07 | A novel continuous flow reactor for low ph viral inactivation |
JP2021518901A JP2022504397A (ja) | 2018-10-08 | 2019-10-07 | 低pHウイルス不活化のための新しい連続フロー反応器 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021518901A Division JP2022504397A (ja) | 2018-10-08 | 2019-10-07 | 低pHウイルス不活化のための新しい連続フロー反応器 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2023055813A JP2023055813A (ja) | 2023-04-18 |
JP7553619B2 true JP7553619B2 (ja) | 2024-09-18 |
Family
ID=68343484
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021518901A Pending JP2022504397A (ja) | 2018-10-08 | 2019-10-07 | 低pHウイルス不活化のための新しい連続フロー反応器 |
JP2023011968A Active JP7553619B2 (ja) | 2018-10-08 | 2023-01-30 | 低pHウイルス不活化のための新しい連続フロー反応器 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021518901A Pending JP2022504397A (ja) | 2018-10-08 | 2019-10-07 | 低pHウイルス不活化のための新しい連続フロー反応器 |
Country Status (10)
Country | Link |
---|---|
US (1) | US20210380914A1 (ja) |
EP (1) | EP3864131A1 (ja) |
JP (2) | JP2022504397A (ja) |
KR (1) | KR20210073554A (ja) |
CN (1) | CN113015787A (ja) |
AU (1) | AU2019357965A1 (ja) |
CA (1) | CA3115253A1 (ja) |
MA (1) | MA53856A (ja) |
SG (1) | SG11202103443XA (ja) |
WO (1) | WO2020076681A1 (ja) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020076575A1 (en) * | 2018-10-08 | 2020-04-16 | Boehringer Ingelheim International Gmbh | A system and method to determine critical process parameters for a continuous viral inactivation reactor to design and manufacture same |
US20230167417A1 (en) * | 2020-04-30 | 2023-06-01 | Massachusetts Institute Of Technology | Model-based control for column-based continuous viral inactivation of biopharmaceuticals |
AU2021293805A1 (en) * | 2020-06-16 | 2022-12-22 | Boehringer Ingelheim International Gmbh | A method of providing a homogeneous feed stream within a plug flow reactor |
TW202233645A (zh) * | 2020-11-09 | 2022-09-01 | 美商安進公司 | pH探針校準狀態的過程中驗證 |
DE102021107394A1 (de) * | 2021-03-24 | 2022-09-29 | Sartorius Stedim Biotech Gmbh | Vorrichtung zur kontinuierlichen Vireninaktivierung |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016173982A1 (de) | 2015-04-28 | 2016-11-03 | Bayer Technology Services Gmbh | Verfahren zur kontinuierlichen virusinaktivierung in einem mikroreaktor |
US20160375159A1 (en) | 2014-03-11 | 2016-12-29 | Bayer Aktiengesellschaft | Device and method for continuous virus inactivation |
WO2017156355A1 (en) | 2016-03-11 | 2017-09-14 | Boehringer Ingelheim International Gmbh | Methods for continuously inactivating a virus during manufacture of a protein |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19634450A1 (de) * | 1996-08-26 | 1998-03-05 | Basf Ag | Vorrichtung zur kontinuierlichen Durchführung chemischer Reaktionen |
US10435670B2 (en) * | 2014-04-15 | 2019-10-08 | Boehringer Ingelheim International Gmbh | Methods, apparatuses, and systems for continuously inactivating a virus during manufacture of a biological product |
EP3031518B1 (en) * | 2014-12-08 | 2021-01-20 | Lonza Ltd | Fluid mixing structure, continuous reaction unit, continuous reaction reactor and method of using the same |
WO2020076575A1 (en) * | 2018-10-08 | 2020-04-16 | Boehringer Ingelheim International Gmbh | A system and method to determine critical process parameters for a continuous viral inactivation reactor to design and manufacture same |
US20230064241A1 (en) * | 2020-02-03 | 2023-03-02 | Merck Patent Gmbh | Modular incubation chamber and method of virus inactivation |
-
2019
- 2019-10-07 KR KR1020217013840A patent/KR20210073554A/ko unknown
- 2019-10-07 EP EP19794331.9A patent/EP3864131A1/en active Pending
- 2019-10-07 CN CN201980075432.XA patent/CN113015787A/zh active Pending
- 2019-10-07 SG SG11202103443XA patent/SG11202103443XA/en unknown
- 2019-10-07 CA CA3115253A patent/CA3115253A1/en active Pending
- 2019-10-07 AU AU2019357965A patent/AU2019357965A1/en active Pending
- 2019-10-07 JP JP2021518901A patent/JP2022504397A/ja active Pending
- 2019-10-07 WO PCT/US2019/054959 patent/WO2020076681A1/en unknown
- 2019-10-07 US US17/283,281 patent/US20210380914A1/en active Pending
- 2019-10-07 MA MA053856A patent/MA53856A/fr unknown
-
2023
- 2023-01-30 JP JP2023011968A patent/JP7553619B2/ja active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20160375159A1 (en) | 2014-03-11 | 2016-12-29 | Bayer Aktiengesellschaft | Device and method for continuous virus inactivation |
WO2016173982A1 (de) | 2015-04-28 | 2016-11-03 | Bayer Technology Services Gmbh | Verfahren zur kontinuierlichen virusinaktivierung in einem mikroreaktor |
WO2017156355A1 (en) | 2016-03-11 | 2017-09-14 | Boehringer Ingelheim International Gmbh | Methods for continuously inactivating a virus during manufacture of a protein |
Non-Patent Citations (1)
Title |
---|
Biotechnology and bioengineering,2018年03月,Vol.115,p.606-616 |
Also Published As
Publication number | Publication date |
---|---|
CA3115253A1 (en) | 2020-04-16 |
EP3864131A1 (en) | 2021-08-18 |
CN113015787A (zh) | 2021-06-22 |
US20210380914A1 (en) | 2021-12-09 |
KR20210073554A (ko) | 2021-06-18 |
JP2022504397A (ja) | 2022-01-13 |
MA53856A (fr) | 2022-01-12 |
SG11202103443XA (en) | 2021-05-28 |
AU2019357965A1 (en) | 2021-04-29 |
WO2020076681A1 (en) | 2020-04-16 |
JP2023055813A (ja) | 2023-04-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7553619B2 (ja) | 低pHウイルス不活化のための新しい連続フロー反応器 | |
Klutz et al. | Narrow residence time distribution in tubular reactor concept for Reynolds number range of 10–100 | |
Wicklein et al. | Good modelling practice in applying computational fluid dynamics for WWTP modelling | |
Gupta et al. | On the CFD modelling of Taylor flow in microchannels | |
Parker et al. | Design of a novel continuous flow reactor for low pH viral inactivation | |
Haidari et al. | Visualization of hydraulic conditions inside the feed channel of Reverse Osmosis: A practical comparison of velocity between empty and spacer-filled channel | |
Kumar et al. | Slug flow in curved microreactors: hydrodynamic study | |
Saad et al. | Experimental distribution of phases and pressure drop in a two-phase offset strip fin type compact heat exchanger | |
JP7340602B2 (ja) | ウイルス不活化のための連続フロー反応器 | |
Mazur et al. | Additively manufactured, highly-uniform flow distributor for process intensification | |
Kashid et al. | On the hydrodynamics of liquid–liquid slug flow capillary microreactors | |
Griffini et al. | Effect of microchannel plate design on fluid flow uniformity at low flow rates | |
Fazli-Abukheyli et al. | Combination of axial dispersion and velocity profile in parallel tanks-in-series compartment model for prediction of residence time distribution in a wide range of non-ideal laminar flow regimes | |
EA027758B1 (ru) | Способ изготовления реактора и система реакторов | |
Xu et al. | Bubble‐separation dynamics in a planar cyclone: experiments and CFD simulations | |
Zhao et al. | Intensification of mixing efficiency and reduction of pressure drop in a millimeter scale T-junction mixer optimized by an elliptical array hole structure | |
Fatemi et al. | Continuous crystallization of paracetamol exploiting gas–liquid flow in modular nucleation and growth stages | |
Yu et al. | Bubble Morphology Analysis and Pressure Drop of Gas–Liquid Two-Phase Flow inside a Quarto Static Mixer | |
Tarlet et al. | Design and mixing performance characterization of a mini-channel mixer with nature-inspired geometries | |
Pakhomov | Modeling of bubble dynamics and heat transfer in polydispersed two-phase turbulent flow in a vertical pipe | |
Jin et al. | Investigation of hydrodynamic and heat transfer characteristics of gas-liquid Taylor flow in square microchannel | |
Tollkötter et al. | Gas–Liquid Flow Dispersion in Micro-Orifices and Bubble Coalescence With High Flow Rates | |
Yang et al. | Enhanced liquid–liquid mass transfer in a monolithic reactor with multi-jet-channel in the circumferential array | |
Biswas et al. | Droplet splitting in multi‐furcating microchannel: A three‐dimensional numerical simulation study | |
Hopley | Liquid residence time distribution in micro-reactors with complex geometries |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20230130 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20231219 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20240226 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240515 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20240820 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20240905 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7553619 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |